These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 14523347)

  • 21. Functional responses of estrogen receptors in the male and female auditory system.
    Charitidi K; Meltser I; Tahera Y; Canlon B
    Hear Res; 2009 Jun; 252(1-2):71-8. PubMed ID: 19450435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigations with cultured human microglia on pathogenic mechanisms of Alzheimer's disease and other neurodegenerative diseases.
    Walker DG; Lue LF
    J Neurosci Res; 2005 Aug; 81(3):412-25. PubMed ID: 15957156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sex dimorphisms in the neuroprotective effects of estrogen in an animal model of Parkinson's disease.
    Gillies GE; Murray HE; Dexter D; McArthur S
    Pharmacol Biochem Behav; 2004 Jul; 78(3):513-22. PubMed ID: 15251260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen signaling in the hypothalamus.
    Kelly MJ; Qiu J; Rønnekleiv OK
    Vitam Horm; 2005; 71():123-45. PubMed ID: 16112267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross-talk between estrogen receptors and insulin-like growth factor-I receptor in the brain: cellular and molecular mechanisms.
    Mendez P; Wandosell F; Garcia-Segura LM
    Front Neuroendocrinol; 2006 Dec; 27(4):391-403. PubMed ID: 17049974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protease-activated receptors in the brain: receptor expression, activation, and functions in neurodegeneration and neuroprotection.
    Luo W; Wang Y; Reiser G
    Brain Res Rev; 2007 Dec; 56(2):331-45. PubMed ID: 17915333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monocyte-macrophage system as a target for estrogen and selective estrogen receptor modulators.
    Härkönen PL; Väänänen HK
    Ann N Y Acad Sci; 2006 Nov; 1089():218-27. PubMed ID: 17261769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implications for estrogens in Parkinson's disease: an epidemiological approach.
    Ragonese P; D'Amelio M; Savettieri G
    Ann N Y Acad Sci; 2006 Nov; 1089():373-82. PubMed ID: 17261781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen provides neuroprotection against activated microglia-induced dopaminergic neuronal injury through both estrogen receptor-alpha and estrogen receptor-beta in microglia.
    Liu X; Fan XL; Zhao Y; Luo GR; Li XP; Li R; Le WD
    J Neurosci Res; 2005 Sep; 81(5):653-65. PubMed ID: 16013043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen, beta-amyloid metabolism/trafficking, and Alzheimer's disease.
    Xu H; Wang R; Zhang YW; Zhang X
    Ann N Y Acad Sci; 2006 Nov; 1089():324-42. PubMed ID: 17261779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogens, brain, and behavior: lessons from knockout mouse models.
    Hill RA; Boon WC
    Semin Reprod Med; 2009 May; 27(3):218-28. PubMed ID: 19401953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prothrombin/thrombin and the thrombin receptors PAR-1 and PAR-4 in the brain: localization, expression and participation in neurodegenerative diseases.
    Sokolova E; Reiser G
    Thromb Haemost; 2008 Oct; 100(4):576-81. PubMed ID: 18841278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of estrogen in the central nervous system].
    Xiao L; Qiu J; Sun G; Chen YZ
    Sheng Li Ke Xue Jin Zhan; 2001 Jan; 32(1):27-30. PubMed ID: 12545773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogens and anti-estrogens: key mediators of prostate carcinogenesis and new therapeutic candidates.
    Ho SM
    J Cell Biochem; 2004 Feb; 91(3):491-503. PubMed ID: 14755680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications.
    Brann DW; Dhandapani K; Wakade C; Mahesh VB; Khan MM
    Steroids; 2007 May; 72(5):381-405. PubMed ID: 17379265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are estrogens protective or risk factors in brain injury and neurodegeneration? Reevaluation after the Women's health initiative.
    Wise PM; Dubal DB; Rau SW; Brown CM; Suzuki S
    Endocr Rev; 2005 May; 26(3):308-12. PubMed ID: 15851820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroprotective effects of estrogens: potential mechanisms of action.
    Green PS; Simpkins JW
    Int J Dev Neurosci; 2000; 18(4-5):347-58. PubMed ID: 10817919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is the role of estrogens and estrogen receptors in epilepsy still underestimated?
    Fucic A; Miskov S; Zeljezić D; Bogdanovic N; Katić J; Gjergja R; Karelson E; Gamulin M
    Med Hypotheses; 2009 Nov; 73(5):703-5. PubMed ID: 19493633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogens: mechanisms of neuroprotective effects.
    Petrovska S; Dejanova B; Jurisic V
    J Physiol Biochem; 2012 Sep; 68(3):455-60. PubMed ID: 22371015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.